The Highly Potent Bromodomain (BRD) Inhibitor FV-281 Displays Preclinical Efficacy in Acute Myeloid Leukemia (AML) von Wang, Zezhou, Dove, Peter, Shamas-Din, Aisha, Hurren, Rose, Wang, Xiaoming, MacLean, Neil, Gronda, Marcela, Bo, Feng, Li, Janessa, Skorupski, Clarissa, Hadri, Wissam, O'Neill, David, Aman, Ahmed, Al-awar, Rima, Minden, Mark D., Slassi, Malik, Schimmer, Aaron D.

Volltext